Citation Impact
Citing Papers
Gastrin-Releasing Peptide (GRP) Analogues for Cancer Imaging
2004
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
Neonatal Systemic AAV Induces Tolerance to CNS Gene Therapy in MPS I Dogs and Nonhuman Primates
2015
Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines
2004
Formation and Function of the Myofibroblast during Tissue Repair
2007 Standout
JNK mediates TGF‐β1‐induced epithelial mesenchymal transdifferentiation of mouse transformed keratinocytes
2006
Superior In vivo Transduction of Human Hepatocytes Using Engineered AAV3 Capsid
2016 StandoutNobel
The Pharmacological Chaperone AT2220 Increases Recombinant Human Acid α-Glucosidase Uptake and Glycogen Reduction in a Mouse Model of Pompe Disease
2012
Neuropeptides and Neuropeptide Receptors in the Drosophila melanogaster Genome
2001
Differential expression of 37 selected genes in hormone‐refractory prostate cancer using quantitative taqman real‐time RT‐PCR
2004
Cellular and molecular mechanisms of fibrosis
2007 Standout
DNA methyltransferase 3B mutations linked to the ICF syndrome cause dysregulation of lymphogenesis genes
2001
Differentiation of Human Circulating Fibrocytes as Mediated by Transforming Growth Factor-β and Peroxisome Proliferator-activated Receptor γ
2007
Small Targeted Cytotoxics: Current State and Promises from DNA‐Encoded Chemical Libraries
2013
Drug-targeting strategies in cancer therapy
2001
Somatostatin receptor sst1–sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands
2001
Lipid nanoparticles for mRNA delivery
2021 Standout
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF‐β1 involves MAPK, Smad and AP‐1 signalling pathways
2005
Transforming Growth Factor-β Signaling in Immunity and Cancer
2019 Standout
Translational Potential of Immune Tolerance Induction by AAV Liver-Directed Factor VIII Gene Therapy for Hemophilia A
2020
TGF-β: the master regulator of fibrosis
2016 Standout
Cancer Statistics, 2006
2006 Standout
Encoded libraries of chemically modified peptides
2015 StandoutNobel
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
A review of stimuli-responsive nanocarriers for drug and gene delivery
2008 Standout
Adeno-Associated Virus Antibody Profiles in Newborns, Children, and Adolescents
2011
Arrestin Development: Emerging Roles for β-arrestins in Developmental Signaling Pathways
2009 StandoutNobel
Stimuli-responsive nanocarriers for drug delivery
2013 Standout
Does the GH–IGF axis play a role in cancer pathogenesis?
2000
Neurotransmitters and Chemokines Regulate Tumor Cell Migration: Potential for a New Pharmacological Approach to Inhibit Invasion and Metastasis Development
2005
Amniotic fluid stabilized lipid nanoparticles for in utero intra-amniotic mRNA delivery
2021 StandoutNobel
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer
2006 Standout
Two to Tango: Regulation of Mammalian Iron Metabolism
2010 Standout
Blinded by the Light: The Growing Complexity of p53
2009 Standout
Polymer conjugates as anticancer nanomedicines
2006 Standout
Non-viral vectors for gene-based therapy
2014 Standout
TGF-β Signaling via TAK1 Pathway: Role in Kidney Fibrosis
2012
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases
2007 Standout
DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals
2003
Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration
2018
The Ectodomain of the Luteinizing Hormone Receptor Interacts with Exoloop 2 to Constrain the Transmembrane Region
2002 StandoutNobel
G6PC mRNA Therapy Positively Regulates Fasting Blood Glucose and Decreases Liver Abnormalities in a Mouse Model of Glycogen Storage Disease 1a
2018
Strain‐Promoted Copper‐Free “Click” Chemistry for 18F Radiolabeling of Bombesin
2011 StandoutNobel
Systemic AAV9 gene transfer in adult GM1 gangliosidosis mice reduces lysosomal storage in CNS and extends lifespan
2015
In vivo genome editing using Staphylococcus aureus Cas9
2015 StandoutNature
Expression of serotonin receptors and role of serotonin in human prostate cancer tissue and cell lines
2004
Natural Product Hybrids as New Leads for Drug Discovery
2003 Standout
The potential of adeno-associated viral vectors for gene delivery to muscle tissue
2014
Systemic sclerosis: a prototypic multisystem fibrotic disorder
2007 Standout
Glycogen autophagy
2004
Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges
2011
Recent developments in the field of antitumour anthracyclines
2001
Adeno-associated virus vector as a platform for gene therapy delivery
2019 Standout
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Nuclear Imaging of Prostate Cancer with Gastrin-Releasing-Peptide- Receptor Targeted Radiopharmaceuticals
2008
Insights into social insects from the genome of the honeybee Apis mellifera
2006 StandoutNature
Gastrin releasing peptide (GRP) receptor targeted radiopharmaceuticals: A concise update
2003
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Molecular Mechanisms of Transactivation and Doxorubicin-mediated Repression of survivin Gene in Cancer Cells
2006
Nuclear factor-κB
2004 Standout
Somatostatin Analog Therapy in Treatment of Gastrointestinal Disorders and Tumors
2003
Monoclonal antibody 2C5-modified doxorubicin-loaded liposomes with significantly enhanced therapeutic activity against intracranial human brain U-87 MG tumor xenografts in nude mice
2007
Development of gene transfer for induction of antigen-specific tolerance
2014
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
2006 Standout
Ghrelin: Structure and Function
2005 Standout
Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q
2003
The role of immune tolerance induction in restoration of the efficacy of ERT in Pompe disease
2012
TGF-β-induced epithelial to mesenchymal transition
2009 Standout
Hypothalamic Hormones and Cancer
2001 Nobel
Emerging Issues in AAV-Mediated In Vivo Gene Therapy
2017
Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification
2011
Autophagy in the liver: functions in health and disease
2017
DNA methylation and human disease
2005 Standout
The dawning era of polymer therapeutics
2003 Standout
Improved Induction of Immune Tolerance to Factor IX by Hepatic AAV-8 Gene Transfer
2009
Unraveling the Complex Story of Immune Responses to AAV Vectors Trial After Trial
2017
Copackaged AAV9 Vectors Promote Simultaneous Immune Tolerance and Phenotypic Correction of Pompe Disease
2015
Prolonged Gene Expression in Muscle Is Achieved Without Active Immune Tolerance Using MicrorRNA 142.3p-Regulated rAAV Gene Transfer
2013
Hepatocyte-targeted HFE and TFR2 control hepcidin expression in mice
2010
Pharmacotherapy of Pompe disease
2013
Engineering Adolescence
2014 Standout
Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transfer
2007
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Hypothalamic Hormones and Cancer
1982
Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer
2006 Standout
Remote Triggered Release of Doxorubicin in Tumors by Synergistic Application of Thermosensitive Liposomes and Gold Nanorods
2011
The TGFβ activated kinase TAK1 regulates vascular development in vivo
2006
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts.
2004
Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer
2023 StandoutNobel
Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells.
2003
Relaxin Augments BMP-2–Induced Osteoblast Differentiation and Bone Formation
2014 Standout
MicroPET Imaging of a Gastrin-Releasing Peptide Receptor-Positive Tumor in a Mouse Model of Human Prostate Cancer Using a 64Cu-Labeled Bombesin Analogue
2003
Non-Smad TGF-β signals
2005 Standout
Ionizable lipid nanoparticles for in utero mRNA delivery
2021 StandoutNobel
Combination therapy in combating cancer
2017 Standout
Radiometallation of receptor-specific peptides for diagnosis and treatment of human cancer.
2005
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
Immune responses to AAV vectors: overcoming barriers to successful gene therapy
2013
Natural product and natural product derived drugs in clinical trials
2014 Standout
Molecular Genetics of Lung Cancer
2003
The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems
2012 Standout
Cure of SCID mice bearing human B-lymphoma xenografts by an anti-CD74 antibody-anthracycline drug conjugate.
2003
Induction of antigen-specific CD4+ T-cell anergy and deletion by in vivo viral gene transfer
2004
Powerful Inhibition of Experimental Human Pancreatic Cancers by Receptor Targeted Cytotoxic LH-RH analog AEZS-108
2013 Nobel
[ 64 Cu-NOTA-8-Aoc-BBN(7-14)NH 2 ] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissues
2007
Integrin α3β1–dependent β-catenin phosphorylation links epithelial Smad signaling to cell contacts
2009
Regulation of Mammalian Autophagy in Physiology and Pathophysiology
2010 Standout
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
2003
Works of Baodong Sun being referenced
Starch Binding Domain-containing Protein 1 Plays a Dominant Role in Glycogen Transport to Lysosomes in Liver
2016
Enhanced Efficacy of an AAV Vector Encoding Chimeric, Highly Secreted Acid α-Glucosidase in Glycogen Storage Disease Type II
2006
Correction of Multiple Striated Muscles in Murine Pompe Disease Through Adeno-associated Virus–mediated Gene Therapy
2008
Packaging of an AAV vector encoding human acid α-glucosidase for gene therapy in glycogen storage disease type II with a modified hybrid adenovirus-AAV vector
2003
Inhibition of growth of human malignant glioblastoma in nude mice by antagonists of bombesin/gastrin-releasing peptide
1999 Nobel
The presence of receptors for bombesin/GRP and mRNA for three receptor subtypes in human ovarian epithelial cancers
2000 Nobel
Enhanced efficacy of enzyme replacement therapy in Pompe disease through mannose-6-phosphate receptor expression in skeletal muscle
2011
in vivo inhibition of PC-3 human androgen-independent prostate cancer by a targeted cytotoxic bombesin analogue, AN-215
2000 Nobel
Hydrostatic isolated limb perfusion with adeno-associated virus vectors enhances correction of skeletal muscle in Pompe disease
2010
Efficacy of an Adeno-associated Virus 8-Pseudotyped Vector in Glycogen Storage Disease Type II
2004
Pathogenesis of growth failure and partial reversal with gene therapy in murine and canine Glycogen Storage Disease type Ia
2013
Efficacy of Helper-dependent Adenovirus Vector-mediated Gene Therapy in Murine Glycogen Storage Disease Type Ia
2007
A pilot study on using rapamycin-carrying synthetic vaccine particles (SVP) in conjunction with enzyme replacement therapy to induce immune tolerance in Pompe disease
2017
Evasion of Immune Responses to Introduced Human Acid α-Glucosidase by Liver-Restricted Expression in Glycogen Storage Disease Type II
2005
Long-term correction of glycogen storage disease type II with a hybrid Ad-AAV vector
2003
Correction of glycogen storage disease type II by an adeno-associated virus vector containing a muscle-specific promoter
2005
AAV Vector-mediated Reversal of Hypoglycemia in Canine and Murine Glycogen Storage Disease Type Ia
2008
Presence of receptors for bombesin/gastrin-releasing peptide and mRNA for three receptor subtypes in human prostate cancers
2000 Nobel
RAPID COMMUNICATION: Human Ovarian Cancers Express Somatostatin Receptors
2000 Nobel
Methylation of the FSHD Syndrome-Linked Subtelomeric Repeat in Normal and FSHD Cell Cultures and Tissues
2001
Targeted cytotoxic analogue of bombesin/ gastrin-releasing peptide inhibits the growth of H-69 human small-cell lung carcinoma in nude mice
1999 Nobel
Enhanced Response to Enzyme Replacement Therapy in Pompe Disease after the Induction of Immune Tolerance
2007
Inhibition of growth of OV-1063 human epithelial ovarian cancers and c-jun and c-fos oncogene expression by bombesin antagonists
2000 Nobel
Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia
2006
Requirement of TGF‐β receptor‐dependent activation of c‐Jun N‐terminal kinases (JNKs)/stress‐activated protein kinases (Sapks) for TGF‐β up‐regulation of the urokinase‐type plasminogen activator receptor
2003
Immunomodulatory Gene Therapy Prevents Antibody Formation and Lethal Hypersensitivity Reactions in Murine Pompe Disease
2009
Immunodominant Liver-Specific Expression Suppresses Transgene-Directed Immune Responses in Murine Pompe Disease
2012
Inhibition of PC-3 human androgen-independent prostate cancer and its metastases by cytotoxic somatostatin analogue AN-238.
1999 Nobel
ABL1 promoter methylation can exist independently of BCR-ABL transcription in chronic myeloid leukemia hematopoietic progenitors.
2001
Targeted cytotoxic somatostatin analogue AN-238 inhibits somatostatin receptor-positive experimental colon cancers independently of their p53 status.
2002 Nobel
Regression of U-87 MG human glioblastomas in nude mice after treatment with a cytotoxic somatostatin analog AN-238.
2000 Nobel
Inhibition of growth of MX-1, MCF-7-MIII and MDA-MB-231 human breast cancer xenografts after administration of a targeted cytotoxic analog of somatostatin, AN-238
1999 Nobel
Targeting of cytotoxic somatostatin analog AN-238 to somatostatin receptor subtypes 5 and/or 3 in experimental pancreatic cancers.
2001 Nobel
High Expression of Somatostatin Receptors and Messenger Ribonucleic Acid for Its Receptor Subtypes in Organ-Confined and Locally Advanced Human Prostate Cancers1
2000 Nobel
Adjunctive β2‐agonists reverse neuromuscular involvement in murine Pompe disease
2012
Inhibition of growth of MDA-MB-468 estrogen-independent human breast carcinoma by bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II
2000 Nobel
Effective treatment of experimental DU-145 prostate cancers with targeted cytotoxic somatostatin analog AN-238
2002 Nobel